Radiotherapy of brain metastases: A 20-case report

Introduction: Brain metastases represent the most common malignant brain tumors, affecting 20-40% of cancer patients. This article examines efficacy in toto encephalic radiotherapy treatment these metastases. Historically, before advent radiotherapy, prognosis for was poor, with a median survival one month. In has played crucial role improving and local control lesions. The aim this study to analyze epidemiological, clinical therapeutic characteristics patients treated by method. Material Method: prospective descriptive included total (TER) between January April 2021. Inclusion criteria were related diagnosis exclusive use radiotherapy. Data collected from medical records analyzed using Microsoft Excel. Quantitative qualitative data processed provide information on population. Results: Results show that mean age 58.55 years, predominance 50-59 group. mainly bronchopulmonary (45%) breast (25%). terms symptoms, 90% symptomatic, while 10% asymptomatic. majority (85%) had more than 3 MRI. As treatment, 70% received at dose 30 Gy 10 fractions, other regimens used remaining cases. Conclusion: remain major problem oncology, significant consequences patient quality life. Although stereotactic is gaining popularity, highlights persistent certain Despite advances modalities, EIT continues play an important management tumors.